AngioDynamics International Life Symposium “The Human Touch, Behind Innovation” March 21–23, 2024

MOBIO to feature Immunophotonics as the Member Highlight for March

Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage and in the March newsletter. MOBIO serves as a representative body for all Missouri entities engaged in life sciences, innovation, and entrepreneurship, promoting advancements in life science research, and fostering economic development. This recognition provides...

AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy

Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of Immunophotonics’ lead asset, IP-001 and AngioDynamics’ ablation devices to explore the power of ablation in combination with immunotherapy for the treatment of solid tumor cancers.  This collaborative effort extends to a partnership with the Cancer...

Wei Chen’s Publication in Acta Biomaterialia Journal

Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K. Lam, and Tomas Hode of Immunophotonics, for their publication titled “N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection” in Acta Biomaterialia, an international journal,...

SIO Annual Scientific Meeting, January 26 – 29, 2024

Tomas Hode, PhD, Co-Founder, CIO, and President at @Immunophotonics, Inc. will be attending the SIO Annual Scientific Meeting January 26 – 29, in Long Beach, CA. Tomas will be connecting with interventional oncology professionals from around the world on the latest developments in improving cancer care alongside medical, surgical and radiation oncology.

Spectrum Conference, January 11 – 14, 2024

Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) are looking forward to attending Spectrum Conference, January 11 – 14, 2024 in Miami, Florida. Leading experts in the field of interventional oncology will be presenting at this prestigious event on the latest advancements in the fight against cancer.

JPM 2024 San Francisco, January 8 – 12, 2024

Our networking is well underway with investors and potential strategic partners for the JPM 2024.  Attending the annual summit Lu Alleruzzo at JPM Healthcare Conference, Theresa Visarius at JPM Biotech Showcase, and Tomas Hode at RESI, in San Francisco January 8 -12, 2024.

Scroll to top